+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide 2014-2023

  • ID: 4771082
  • Report
  • April 2019
  • Region: China, India, Brazil, Russia
  • 115 pages
  • MarketLine
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 2
Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide 2014-2023

Summary

The BRIC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the BRIC pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights
  • Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the pharmaceuticals industry and had a total market value of $219.3 billion in 2018. India was the fastest growing country with a CAGR of 15.4% over the 2014-18 period.
  • Within the pharmaceuticals industry, China is the leading country among the BRIC nations with market revenues of $132.9 billion in 2018. This was followed by India, Russia and Brazil with a value of $38.2, $24.5, and $23.6 billion, respectively.
  • China is expected to lead the pharmaceuticals industry in the BRIC nations with a value of $234.7 billion in 2023, followed by India, Russia, Brazil with expected values of $72.7, $44.9 and $27.9 billion, respectively.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the BRIC pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ BRIC operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the BRIC pharmaceuticals market with five year forecasts
  • Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country
Reasons to buy
  • What was the size of the BRIC pharmaceuticals market by value in 2018?
  • What will be the size of the BRIC pharmaceuticals market in 2023?
  • What factors are affecting the strength of competition in the BRIC pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the BRIC pharmaceuticals market?
Note: Product cover images may vary from those shown
2 of 2
  • Introduction
  • What is this report about?
  • Who is the target reader?
  • How to use this report
  • Definitions
  • BRIC Pharmaceuticals
  • Industry Outlook
  • Pharmaceuticals in Brazil
  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Pharmaceuticals in China
  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Pharmaceuticals in India
  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Pharmaceuticals in Russia
  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Company Profiles
  • Leading Companies
  • Appendix
  • Methodology
List Of Tables
Table 1: BRIC pharmaceuticals industry, revenue($bn), 2014-23
Table 2: BRIC pharmaceuticals industry, revenue($bn), 2014-18
Table 3: BRIC pharmaceuticals industry, revenue($bn), 2018-23
Table 4: Brazil pharmaceuticals market value: $ billion, 2014-18
Table 5: Brazil pharmaceuticals market geography segmentation: $ billion, 2018
Table 6: Brazil pharmaceuticals market share: % share, by value, 2018
Table 7: Brazil pharmaceuticals market value forecast: $ billion, 2018-23
Table 8: Brazil size of population (million), 2014-18
Table 9: Brazil gdp (constant 2005 prices, $ billion), 2014-18
Table 10: Brazil gdp (current prices, $ billion), 2014-18
Table 11: Brazil inflation, 2014-18
Table 12: Brazil consumer price index (absolute), 2014-18
Table 13: Brazil exchange rate, 2014-18
Table 14: China pharmaceuticals market value: $ billion, 2014-18
Table 15: China pharmaceuticals market geography segmentation: $ billion, 2018
Table 16: China pharmaceuticals market share: % share, by value, 2018
Table 17: China pharmaceuticals market value forecast: $ billion, 2018-23
Table 18: China size of population (million), 2014-18
Table 19: China gdp (constant 2005 prices, $ billion), 2014-18
Table 20: China gdp (current prices, $ billion), 2014-18
Table 21: China inflation, 2014-18
Table 22: China consumer price index (absolute), 2014-18
Table 23: China exchange rate, 2014-18
Table 24: India pharmaceuticals market value: $ billion, 2014-18
Table 25: India pharmaceuticals market geography segmentation: $ billion, 2018
Table 26: India pharmaceuticals market share: % share, by value, 2018
Table 27: India pharmaceuticals market value forecast: $ billion, 2018-23
Table 28: India size of population (million), 2014-18
Table 29: India gdp (constant 2005 prices, $ billion), 2014-18
Table 30: India gdp (current prices, $ billion), 2014-18
Table 31: India inflation, 2014-18
Table 32: India consumer price index (absolute), 2014-18
Table 33: India exchange rate, 2014-18
Table 34: Russia pharmaceuticals market value: $ billion, 2014-18
Table 35: Russia pharmaceuticals market geography segmentation: $ billion, 2018
Table 36: Russia pharmaceuticals market share: % share, by value, 2018
Table 37: Russia pharmaceuticals market value forecast: $ billion, 2018-23
Table 38: Russia size of population (million), 2014-18
Table 39: Russia gdp (constant 2005 prices, $ billion), 2014-18
Table 40: Russia gdp (current prices, $ billion), 2014-18
Table 41: Russia inflation, 2014-18
Table 42: Russia consumer price index (absolute), 2014-18
Table 43: Russia exchange rate, 2014-18
Table 44: Ache Laboratorios Farmaceuticos SA: key facts
Table 45: Guangzhou Pharmaceutical Holdings Ltd: key facts
Table 46: Shanghai Pharmaceuticals: key facts
Table 47: Shanghai Pharmaceuticals: key financials ($)
Table 48: Shanghai Pharmaceuticals: key financials (CNY)
Table 49: Shanghai Pharmaceuticals: key financial ratios
Table 50: Yangtze River Pharmaceutical Group: key facts
Table 51: Yunnan Baiyao Group Co Ltd: key facts
Table 52: Yunnan Baiyao Group Co Ltd: key financials ($)
Table 53: Yunnan Baiyao Group Co Ltd: key financials (CNY)
Table 54: Yunnan Baiyao Group Co Ltd: key financial ratios
Table 55: Aurobindo Pharma Limited: key facts
Table 56: Aurobindo Pharma Limited: key financials ($)
Table 57: Aurobindo Pharma Limited: key financials (Rs.)
Table 58: Aurobindo Pharma Limited: key financial ratios
Table 59: Dr. Reddy's Laboratories Limited: key facts
Table 60: Dr. Reddy's Laboratories Limited: key financials ($)

List of Figures
Figure 1: BRIC pharmaceuticals industry, revenue($bn), 2014-23
Figure 2: BRIC pharmaceuticals industry, revenue($bn), 2014-18
Figure 3: BRIC pharmaceuticals industry, revenue($bn), 2018-23
Figure 4: Brazil pharmaceuticals market value: $ billion, 2014-18
Figure 5: Brazil pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 6: Brazil pharmaceuticals market share: % share, by value, 2018
Figure 7: Brazil pharmaceuticals market value forecast: $ billion, 2018-23
Figure 8: Forces driving competition in the pharmaceuticals market in Brazil, 2018
Figure 9: Drivers of buyer power in the pharmaceuticals market in Brazil, 2018
Figure 10: Drivers of supplier power in the pharmaceuticals market in Brazil, 2018
Figure 11: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2018
Figure 12: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2018
Figure 13: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2018
Figure 14: China pharmaceuticals market value: $ billion, 2014-18
Figure 15: China pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 16: China pharmaceuticals market share: % share, by value, 2018
Figure 17: China pharmaceuticals market value forecast: $ billion, 2018-23
Figure 18: Forces driving competition in the pharmaceuticals market in China, 2018
Figure 19: Drivers of buyer power in the pharmaceuticals market in China, 2018
Figure 20: Drivers of supplier power in the pharmaceuticals market in China, 2018
Figure 21: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2018
Figure 22: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2018
Figure 23: Drivers of degree of rivalry in the pharmaceuticals market in China, 2018
Figure 24: India pharmaceuticals market value: $ billion, 2014-18
Figure 25: India pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 26: India pharmaceuticals market share: % share, by value, 2018
Figure 27: India pharmaceuticals market value forecast: $ billion, 2018-23
Figure 28: Forces driving competition in the pharmaceuticals market in India, 2018
Figure 29: Drivers of buyer power in the pharmaceuticals market in India, 2018
Figure 30: Drivers of supplier power in the pharmaceuticals market in India, 2018
Figure 31: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2018
Figure 32: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2018
Figure 33: Drivers of degree of rivalry in the pharmaceuticals market in India, 2018
Figure 34: Russia pharmaceuticals market value: $ billion, 2014-18
Figure 35: Russia pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 36: Russia pharmaceuticals market share: % share, by value, 2018
Figure 37: Russia pharmaceuticals market value forecast: $ billion, 2018-23
Figure 38: Forces driving competition in the pharmaceuticals market in Russia, 2018
Figure 39: Drivers of buyer power in the pharmaceuticals market in Russia, 2018
Figure 40: Drivers of supplier power in the pharmaceuticals market in Russia, 2018
Figure 41: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2018
Figure 42: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2018
Figure 43: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2018
Figure 44: Shanghai Pharmaceuticals: revenues & profitability
Figure 45: Shanghai Pharmaceuticals: assets & liabilities
Figure 46: Yunnan Baiyao Group Co Ltd: revenues & profitability
Figure 47: Yunnan Baiyao Group Co Ltd: assets & liabilities
Figure 48: Aurobindo Pharma Limited: revenues & profitability
Figure 49: Aurobindo Pharma Limited: assets & liabilities
Figure 50: Dr. Reddy's Laboratories Limited: revenues & profitability
Figure 51: Dr. Reddy's Laboratories Limited: assets & liabilities
Figure 52: Lupin Ltd: revenues & profitability
Figure 53: Lupin Ltd: assets & liabilities
Figure 54: Sun Pharmaceutical Industries Ltd: revenues & profitability
Figure 55: Sun Pharmaceutical Industries Ltd: assets & liabilities
Figure 56: Bayer AG: revenues & profitability
Figure 57: Bayer AG: assets & liabilities
Figure 58: Novartis AG: revenues & profitability
Figure 59: Novartis AG: assets & liabilities
Figure 60: Sanofi SA: revenues & profitability
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll